Beta-tricalcium　phosphate　(beta-TCP)　bioceramics　have　an　inorganic　composition　similar　to　the　human　bone.　While　conventional　methods　can　only　produce　ceramic　scaffolds　with　poor　controllability,　the　advancement　of　3D-printing,　especially　stereolithography,　made　it　possible　to　manufacture　controllable,　highly　precise,　micropore　ceramic　scaffolds.　In　this　study,　the　stereolithography　was　applied　to　produce　beta-TCP　bioceramics,　while　ZrO2,　Al2O3,　Ti6Al4V,　and　polyetheretherketone　(PEEK)　were　used　as　controls.　Phase　analysis,　water　contact　angle　tests,　and　Micro-CT　were　applied　to　evaluate　the　surface　properties　and　scaffold.　Hemolytic　toxicity,　cell　proliferation,　and　morphological　assessment　were　performed　to　evaluate　the　biocompatibility.　Alkaline　phosphatase　(ALP)　level,　mineralization,　and　qRT-PCR　were　measured　to　evaluate　the　osteointegration.　During　the　manufacturing　of　beta-TCP,　no　evident　impurity　substance　and　hemolytic　toxicity　was　found.　Cells　on　beta-TCP　had　good　morphologies,　and　their　proliferation　capability　was　similar　to　Ti6Al4V,　which　was　higher　than　the　other　materials.　Cells　on　beta-TCP　had　higher　ALP　levels　than　PEEK.　The　degree　of　mineralization　was　significantly　higher　on　beta-TCP.　The　expression　of　osteogenesis-related　genes　on　beta-TCP　was　similar　to　Ti6Al4V　and　higher　than　the　other　materials.　In　this　study,　the　beta-TCP　produced　by　stereolithography　had　no　toxicity,　high　accuracy,　and　excellent　osteointegration　capability,　thus　resulting　as　a　good　choice　for　bone　implants.